NFKB1 and breast carcinoma: For instance, both AKT and ERK can activate ER by phosphorylation in breast cancer.35, 36 In support of this notion is our finding that ASIC1-mediated NF-κB activation can bypass AKT through ERK, especially in the case that AKT is constitutively activated.